{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"paraneoplastic-cerebellar-degeneration","columns":[{"gene":"","key":"population-2ac96480aa5dd6253de8","label":"Paraneoplastic cerebellar degeneration","mondoId":"MONDO:0044877","onsetQualifier":null,"originColumnKey":"MONDO:0044877/ORPHA:623626","originalViews":[{"key":"MONDO:0044877/ORPHA:623626","label":"Paraneoplastic cerebellar degeneration","scopeLabel":"ORPHA:623626","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["08658bd62768c99c8a9507f6c174a7e14019bf7dec09f028029578b14213f1d8","0ec6476e48cdf53534833b2d682828b7e2f1e9149114d7c4e32e884687e22007","24f7425e280c1eeeb1c17816866ff312ddab081ee02ccc0a593af37f104548e4","275059d2368812d9638e0c075e2e9b289480aecd7c198a9b975016e4dc7d1e6d","2de6edbeb05c701033b2723bdfaf7a1bfa3e5c8f2153130164271879c7a1047f","33850cdefe77d2a3293910782b3a23dc41e676ff80ae31cac0f4355cca11d736","36de47b526459e8925c18eb17cd993aa2478a8032c5289f001c6978161781ef5","61d49387198f76308edac0e4ca4949ce47288f877de7c9a52cf805e5f4531a97","693968c0b888f950501f2b2944332bb241e85cc2421e6038ef402ed0176cbdd6","6ac80e1fc7314d04e8fec6748d2adace1d6545cfca1a26a04705735c69cd332e","716476269ccb886b058d417a40d944adee7e3bf49f67b55690ffbd61ba5cc4a4","797d8c09a3131ea2979b41410db4b224522073f8b305211fa0d3348b263a945d","7e4607645485d9ca7e0b510968dc7fa59a5630d37fcffce6a98f3231d01976ae","87c1fa184274bb305262230a4393d23b3dc356ae881af91a29821e28e66bf861","9ddc91489c06cbab12bc740a0bdcf0d550eb32b21e0e471a64a316eadbb7260b","a081a017f6ab98151131aca72064321b46805fd186d5e0798e58acff58aedf9a","b19de07e9272789a28686f78d2002a1e5ac28e176fc73f837b69db66cb5987ed","c31d0a637bdc18c7d45b238534e29b9415f61967a1027da5cdb6818bfe4355f7","c569f9480543206b4774c0ccf498c2fef529ac772a3942116c0980c1547e0d4d","cb8a070e8b60acd5807e3ea7b2a8c320013d22157454bc493e8281963009b16c","e3e2375ba2d9d25d24af29807e5aec3a467c3bbbb524d3a510d091e0a0a2568c","ec4b0b55b82fedb1fc76cae79f30858d39c041b8e7ca1458d6d02702981d6f64","eff6f15f8d1fcb88abd27156126029a3d512ca3571a7b5a2e6da7b9ee15e60fe","f218d6345097faf6a123994b196a04c298f97ca29c6f39b1e793128d316cacf7"],"recordQualifiers":{},"scopeLabel":"ORPHA:623626","sourceIds":["ORPHA:623626"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-2ac96480aa5dd6253de8"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:5000006","HP:5000016","HP:5000024","HP:5000030","HP:5000034","HP:5000037","HP:0001251"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":24,"sourceGroups":{"orphanet":24}},"features":[{"hpoId":"HP:5000006","label":"Anti-CV2/CRMP5 antibody positivity","primary":true},{"hpoId":"HP:5000016","label":"Anti-Hu antibody positivity","primary":true},{"hpoId":"HP:5000024","label":"Anti-mGluR1 antibody","primary":true},{"hpoId":"HP:5000030","label":"Anti-Ri antibody","primary":true},{"hpoId":"HP:5000034","label":"Anti-Tr/DNER antibody","primary":true},{"hpoId":"HP:5000037","label":"Anti-Yo antibody positivity","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0001272","label":"Cerebellar atrophy","primary":false},{"hpoId":"HP:0100543","label":"Cognitive impairment","primary":false},{"hpoId":"HP:6000397","label":"CSF oligoclonal immunoglobulin G bands","primary":false},{"hpoId":"HP:0012229","label":"CSF pleocytosis","primary":false},{"hpoId":"HP:0000651","label":"Diplopia","primary":false},{"hpoId":"HP:0001260","label":"Dysarthria","primary":false},{"hpoId":"HP:0002015","label":"Dysphagia","primary":false},{"hpoId":"HP:0002315","label":"Headache","primary":false},{"hpoId":"HP:0012189","label":"Hodgkin lymphoma","primary":false},{"hpoId":"HP:0002922","label":"Increased CSF protein concentration","primary":false},{"hpoId":"HP:0011134","label":"Low-grade fever","primary":false},{"hpoId":"HP:0033834","label":"Malaise","primary":false},{"hpoId":"HP:0002017","label":"Nausea and vomiting","primary":false},{"hpoId":"HP:0100013","label":"Neoplasm of the breast","primary":false},{"hpoId":"HP:0000639","label":"Nystagmus","primary":false},{"hpoId":"HP:0100615","label":"Ovarian neoplasm","primary":false},{"hpoId":"HP:0002317","label":"Unsteady gait","primary":false}],"ledeHtml":"A rare, immune-mediated disorder characterized by cerebellar degeneration due to the presence of an often undetected malignancy (usually carcinoma or lymphoma) in an anatomic site other than the cerebellum. Signs and symptoms include progressive ataxia, dysarthria, and nystagmus.","mondoId":"MONDO:0044877","node":{"canonicalSlug":"paraneoplastic-cerebellar-degeneration","comparisons":[{"documentSha256":"66f102ea6c63be3acae0e07dfd5c3acf94e4559c9349bcd82db49e806e769e15","key":"legacy-paraneoplastic-neurologic","kind":"legacy","label":"paraneoplastic neurologic syndrome","memberIds":["MONDO:0015247","MONDO:0018215","MONDO:0018556","MONDO:0019112","MONDO:0044877"],"mondoId":"MONDO:0018215","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/paraneoplastic-neurologic.66f102ea6c63be3acae0e07dfd5c3acf94e4559c9349bcd82db49e806e769e15.json"},{"documentSha256":"658678349cb95eb598f1728eca77787766834efb7ab70fdeb609c6e918418df8","key":"expanded-paraneoplastic-neurologic","kind":"expanded","label":"paraneoplastic neurologic syndrome","memberIds":["MONDO:0006888","MONDO:0015247","MONDO:0015589","MONDO:0015590","MONDO:0017364","MONDO:0018215","MONDO:0018556","MONDO:0019112","MONDO:0044877"],"mondoId":"MONDO:0018215","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-658678349cb95eb598f1.658678349cb95eb598f1728eca77787766834efb7ab70fdeb609c6e918418df8.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Paraneoplastic cerebellar degeneration","originalSourceId":"ORPHA:623626","paragraphs":["A rare, immune-mediated disorder characterized by cerebellar degeneration due to the presence of an often undetected malignancy (usually carcinoma or lymphoma) in an anatomic site other than the cerebellum. Signs and symptoms include progressive ataxia, dysarthria, and nystagmus."],"rawAttribution":"MONDO:0044877","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:43:25Z","upstream":"MONDO:0044877","url":"https://rarediseases.info.nih.gov/diseases/22493"},"ownColumnKeys":["population-2ac96480aa5dd6253de8"],"publication":"published","relationships":[{"kind":"parent","label":"paraneoplastic neurologic syndrome","mondoId":"MONDO:0018215","slug":"paraneoplastic-neurologic"},{"kind":"parent","label":"cerebellar degeneration","mondoId":"MONDO:0022687","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"08658bd62768c99c8a9507f6c174a7e14019bf7dec09f028029578b14213f1d8","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:5000034","is_excluded":false,"label":"Anti-Tr/DNER antibody","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0ec6476e48cdf53534833b2d682828b7e2f1e9149114d7c4e32e884687e22007","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:5000037","is_excluded":false,"label":"Anti-Yo antibody positivity","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"24f7425e280c1eeeb1c17816866ff312ddab081ee02ccc0a593af37f104548e4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002015","is_excluded":false,"label":"Dysphagia","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"275059d2368812d9638e0c075e2e9b289480aecd7c198a9b975016e4dc7d1e6d","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:5000024","is_excluded":false,"label":"Anti-mGluR1 antibody","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2de6edbeb05c701033b2723bdfaf7a1bfa3e5c8f2153130164271879c7a1047f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012229","is_excluded":false,"label":"CSF pleocytosis","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"33850cdefe77d2a3293910782b3a23dc41e676ff80ae31cac0f4355cca11d736","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000651","is_excluded":false,"label":"Diplopia","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"36de47b526459e8925c18eb17cd993aa2478a8032c5289f001c6978161781ef5","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002922","is_excluded":false,"label":"Increased CSF protein concentration","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"61d49387198f76308edac0e4ca4949ce47288f877de7c9a52cf805e5f4531a97","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011134","is_excluded":false,"label":"Low-grade fever","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"693968c0b888f950501f2b2944332bb241e85cc2421e6038ef402ed0176cbdd6","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002017","is_excluded":false,"label":"Nausea and vomiting","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6ac80e1fc7314d04e8fec6748d2adace1d6545cfca1a26a04705735c69cd332e","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:5000006","is_excluded":false,"label":"Anti-CV2/CRMP5 antibody positivity","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"716476269ccb886b058d417a40d944adee7e3bf49f67b55690ffbd61ba5cc4a4","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100615","is_excluded":false,"label":"Ovarian neoplasm","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"797d8c09a3131ea2979b41410db4b224522073f8b305211fa0d3348b263a945d","raw":{"aspect":"P","body_system":"neoplasm","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100013","is_excluded":false,"label":"Neoplasm of the breast","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"7e4607645485d9ca7e0b510968dc7fa59a5630d37fcffce6a98f3231d01976ae","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"87c1fa184274bb305262230a4393d23b3dc356ae881af91a29821e28e66bf861","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002317","is_excluded":false,"label":"Unsteady gait","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9ddc91489c06cbab12bc740a0bdcf0d550eb32b21e0e471a64a316eadbb7260b","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:5000016","is_excluded":false,"label":"Anti-Hu antibody positivity","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a081a017f6ab98151131aca72064321b46805fd186d5e0798e58acff58aedf9a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002315","is_excluded":false,"label":"Headache","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"b19de07e9272789a28686f78d2002a1e5ac28e176fc73f837b69db66cb5987ed","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000639","is_excluded":false,"label":"Nystagmus","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c31d0a637bdc18c7d45b238534e29b9415f61967a1027da5cdb6818bfe4355f7","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:5000030","is_excluded":false,"label":"Anti-Ri antibody","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c569f9480543206b4774c0ccf498c2fef529ac772a3942116c0980c1547e0d4d","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012189","is_excluded":false,"label":"Hodgkin lymphoma","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cb8a070e8b60acd5807e3ea7b2a8c320013d22157454bc493e8281963009b16c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0100543","is_excluded":false,"label":"Cognitive impairment","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e3e2375ba2d9d25d24af29807e5aec3a467c3bbbb524d3a510d091e0a0a2568c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ec4b0b55b82fedb1fc76cae79f30858d39c041b8e7ca1458d6d02702981d6f64","raw":{"aspect":"P","body_system":"other","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0033834","is_excluded":false,"label":"Malaise","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"eff6f15f8d1fcb88abd27156126029a3d512ca3571a7b5a2e6da7b9ee15e60fe","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:6000397","is_excluded":false,"label":"CSF oligoclonal immunoglobulin G bands","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f218d6345097faf6a123994b196a04c298f97ca29c6f39b1e793128d316cacf7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:623626","disease_name":"Paraneoplastic cerebellar degeneration","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:623626","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/22493\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0044877\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0044877</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare, immune-mediated disorder characterized by cerebellar degeneration due to the presence of an often undetected malignancy (usually carcinoma or lymphoma) in an anatomic site other than the cerebellum. Signs and symptoms include progressive ataxia, dysarthria, and nystagmus.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/22493\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"paraneoplastic-cerebellar-degeneration","sourceDocuments":[{"name":"GARD: Paraneoplastic cerebellar degeneration","reviewed":null,"source_release":"2026-10-25T03:43:25Z","url":"https://rarediseases.info.nih.gov/diseases/22493"},{"name":"MONDO: paraneoplastic cerebellar degeneration","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0044877"}],"sourceNote":"","synonyms":["paraneoplastic cerebellar degeneration"],"takeawayHtml":"","title":"paraneoplastic cerebellar degeneration"},"schemaVersion":1}
